Advances in biological agents in the treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic and progressive disease which is currently hard to cure. Traditional treatments, such as aminosalicylates, steroids and immunosuppressants, can only alleviate symptoms, but can’t prevent potential inflammation or change the disease progress. The applicat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2022-08-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/storage/attach/2208/VO4xeZPbBch7s5ayeMl0E67uHzjTH7n8Zocmy2z5.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850120179811352576 |
|---|---|
| author | Na LI Mei YE |
| author_facet | Na LI Mei YE |
| author_sort | Na LI |
| collection | DOAJ |
| description | Inflammatory bowel disease (IBD) is a chronic and progressive disease which is currently hard to cure. Traditional treatments, such as aminosalicylates, steroids and immunosuppressants, can only alleviate symptoms, but can’t prevent potential inflammation or change the disease progress. The application of biological agents represents a turning point in the treatment of IBD. With the expansion of research, an increasing number of new biological agents and small molecule drugs have entered various stages of clinical development. The chief focus of this review is the mechanisms of action and clinical trial data on emerging biological agents and small molecule drugs for the treatment of IBD. |
| format | Article |
| id | doaj-art-e6a4251add794b63aff4b0ca8ad11d17 |
| institution | OA Journals |
| issn | 1004-5511 |
| language | zho |
| publishDate | 2022-08-01 |
| publisher | Editorial Office of New Medicine |
| record_format | Article |
| series | Yixue xinzhi zazhi |
| spelling | doaj-art-e6a4251add794b63aff4b0ca8ad11d172025-08-20T02:35:25ZzhoEditorial Office of New MedicineYixue xinzhi zazhi1004-55112022-08-0132431032010.12173/j.issn.1004-5511.2022040376344Advances in biological agents in the treatment of inflammatory bowel diseaseNa LIMei YEInflammatory bowel disease (IBD) is a chronic and progressive disease which is currently hard to cure. Traditional treatments, such as aminosalicylates, steroids and immunosuppressants, can only alleviate symptoms, but can’t prevent potential inflammation or change the disease progress. The application of biological agents represents a turning point in the treatment of IBD. With the expansion of research, an increasing number of new biological agents and small molecule drugs have entered various stages of clinical development. The chief focus of this review is the mechanisms of action and clinical trial data on emerging biological agents and small molecule drugs for the treatment of IBD.https://yxxz.whuznhmedj.com/storage/attach/2208/VO4xeZPbBch7s5ayeMl0E67uHzjTH7n8Zocmy2z5.pdfinflammatory bowel disease biological agents small molecule drugs therapeutics |
| spellingShingle | Na LI Mei YE Advances in biological agents in the treatment of inflammatory bowel disease Yixue xinzhi zazhi inflammatory bowel disease biological agents small molecule drugs therapeutics |
| title | Advances in biological agents in the treatment of inflammatory bowel disease |
| title_full | Advances in biological agents in the treatment of inflammatory bowel disease |
| title_fullStr | Advances in biological agents in the treatment of inflammatory bowel disease |
| title_full_unstemmed | Advances in biological agents in the treatment of inflammatory bowel disease |
| title_short | Advances in biological agents in the treatment of inflammatory bowel disease |
| title_sort | advances in biological agents in the treatment of inflammatory bowel disease |
| topic | inflammatory bowel disease biological agents small molecule drugs therapeutics |
| url | https://yxxz.whuznhmedj.com/storage/attach/2208/VO4xeZPbBch7s5ayeMl0E67uHzjTH7n8Zocmy2z5.pdf |
| work_keys_str_mv | AT nali advancesinbiologicalagentsinthetreatmentofinflammatoryboweldisease AT meiye advancesinbiologicalagentsinthetreatmentofinflammatoryboweldisease |